Gemcitabine in combination with pegylated liposomal doxorubicin has been recognized as an effective treatment in patients with refractory solid tumors. To our knowledge, this is the first case of relapsed Hodgkin lymphoma with breast involvement successfully treated with this association.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1600-0609.2005.00558.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!